Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON
  1. Startseite
  2. Aktien
  3. Deutschland
  4. Xetra
  5. MorphoSys AG
  6. News
  7. Andere Sprachen
    MOR   DE0006632003   663200

MORPHOSYS AG

(MOR)
  Bericht
Realtime Estimate-Kurse. Realtime-Estimate Tradegate - 17.09. 15:55:21
41.28 EUR   +2.51%
06:20ÜBERBLICK/Anstehende Indexänderungen
DJ
15.09.Europäische ADRs am Mittwoch leicht höher, da Energieaktien sich erholen
MT
15.09.ÜBERBLICK/Anstehende Indexänderungen
DJ
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über MORPHOSYS AG
15.09.European ADRs Modestly Higher Wednesday as Energy Stocks Rally
13.09.OPINIONES DE LOS ANALISTAS DEL DÍA : Acciona, BMW, Allianz, Getlink, Rio Tinto, ..
13.09.BÖRSE MADRID : Los mercados se quedan sin combustible
13.09.BÖRSE PARIS : Des marchés en panne de carburant
13.09.AVIS D'ANALYSTES DU JOUR : BMW, Allianz, Getlink, Ubisoft, Neoen, Polypeptide, V..
10.09.European ADRs Move Higher in Friday Trading
08.09.European ADRs Move Lower in Wednesday Trading
07.09.European ADRs Move Lower in Tuesday Trading
01.09.European ADRs Move Higher in Wednesday Trading
01.09.BÖRSE MADRID : El apoyo, cuando nos retienen
31.08.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
31.08.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
30.08.European ADRs Move Slightly Higher in Monday Trading
27.08.MORPHOSYS : The decision by the European Commission is based on data from the L-..
27.08.INCYTE : et MorphoSys annoncent l'approbation par la Commission européenne de Mi..
27.08.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
27.08.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
26.08.INCYTE : MorphoSys Treatment for Large B-Cell Lymphoma Gets Conditional Marketin..
26.08.MORPHOSYS : and Incyte Announce the European Commission Approval of Minjuvi(R) (..
26.08.MORPHOSYS : and Incyte Announce the European Commission Approval of Minjuvi(R) (..
26.08.PRESS RELEASE : MorphoSys and Incyte Announce the -2-
26.08.INCYTE : and MorphoSys Announce the European Commission Approval of Minjuvi® (ta..
26.08.PRESS RELEASE : MorphoSys and Incyte Announce the European Commission Approval o..
25.08.European ADRs Slightly Higher Wednesday Morning
25.08.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
25.08.DGAP-PVR : MorphoSys AG: Release according to Article 40, Section 1 of the WpHG ..
25.08.MORPHOSYS : Health Canada Grants Marketing Authorization for Minjuvi® (tafasitam..
25.08.Health Canada Grants Marketing Authorization for Minjuvi® (Tafasitamab) in Co..
24.08.MORPHOSYS : Health Canada Grants Marketing Authorization for Minjuvi(R) (tafasit..
24.08.MORPHOSYS : Health Canada Grants Marketing Authorization for Minjuvi(R) (tafasit..
24.08.PRESS RELEASE : Health Canada Grants Marketing -2-
24.08.PRESS RELEASE : Health Canada Grants Marketing Authorization for Minjuvi(R) (taf..
24.08.INCYTE : Canada Approves Minjuvi in Combination With Lenalidomide for Lymphoma
20.08.European ADRs Move Higher in Friday Trading
20.08.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
20.08.DGAP-PVR : MorphoSys AG: Release according to Article 40, Section 1 of the WpHG ..
18.08.European ADRs Move Slightly Higher in Wednesday Trading
18.08.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
18.08.DGAP-PVR : MorphoSys AG: Release according to Article 40, Section 1 of the WpHG ..
18.08.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
17.08.MORPHOSYS' : Partner Incyte Announced Development and Commercialization Agreemen..
17.08.MORPHOSYS : Incyte Grants InnoCare Rights to Tafasitamab in Greater China
17.08.MORPHOSYS' : Partner Incyte Announced Development and Commercialization Agreemen..
17.08.MORPHOSYS' : Partner Incyte Announced Development and Commercialization Agreemen..
17.08.PRESS RELEASE : MorphoSys' Partner Incyte Announced Development and Commercializ..
16.08.European ADRs Move Lower in Monday Trading
13.08.European ADRs Move Higher in Friday Trading
12.08.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
12.08.DGAP-PVR : MorphoSys AG: Release according to Article 40, Section 1 of the WpHG ..
09.08.European ADRs Move Higher in Monday Trading
06.08.European ADRs Move Lower in Friday Trading
06.08.Bolsa de Madrid : El verano sin fin
06.08.BÖRSE PARIS : The Endless Summer
06.08.AVIS D'ANALYSTES DU JOUR : Stellantis, Adidas, Eurofins, Nestlé, Sodexo, Siemens..
05.08.European ADRs Move Higher in Thursday Trading
04.08.European ADRs Move Slightly Higher in Wednesday Trading
04.08.BÖRSE MADRID : No hay otras alternativas
04.08.AVIS D'ANALYSTES DU JOUR : Airbus, Schneider, Engie, Legrand, Société Générale, ..
04.08.BÖRSE PARIS : Il n'y a pas d'autres alternatives
03.08.European ADRs Move Higher in Tuesday Trading
03.08.MORPHOSYS AG : Notification and public disclosure of transactions by persons
02.08.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
02.08.MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
02.08.MORPHOSYS : Notification of managers`transactions according to article 19 MAR (F..
02.08.CORRECTION OF A RELEASE FROM 30/07/2 : 30 CET/CEST - MorphoSys AG: Release accor..
02.08.DGAP-NVR : Correction of a release from 30/07/2021, 14:30 CET/CEST - MorphoSys A..
30.07.MORPHOSYS AG : Notification and public disclosure of transactions by persons
30.07.MORPHOSYS AG : Release according to Article 41 of the WpHG [the German Securitie..
30.07.MORPHOSYS AG : Release according to Article 41 of the WpHG [the German Securitie..
29.07.MORPHOSYS : Reports Second Quarter and First Half 2021 Results (Form 6-K)
29.07.MORPHOSYS : Q2 Net Earnings Positive, Revenue Up; Raises Fiscal Full-Year Outloo..
29.07.MorphoSys Ag Announces Executive Changes
28.07.MORPHOSYS : Reports Second Quarter and First Half 2021 Results
28.07.PRESS RELEASE : MorphoSys AG Reports Second -3-
28.07.PRESS RELEASE : MorphoSys AG Reports Second -2-
1  2  3  4  5  6  7  8  9  10Weiter
Anstehende Termine für MORPHOSYS AG